Participation of Black Americans in Cancer Clinical Trials: Current Challenges and Proposed Solutions | Zendy

Muhammad Awidi | Zendy; Samer Al Hadidi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Participation of Black Americans in Cancer Clinical Trials: Current Challenges and Proposed Solutions

Author(s) -

Muhammad Awidi,

Samer Al Hadidi

Publication year - 2021

Publication title -

jco oncology practice

Language(s) - English

Resource type - Journals

eISSN - 2688-1535

pISSN - 2688-1527

DOI - 10.1200/op.21.00001

Subject(s) - clinical trial , dilemma , cancer , medicine , race (biology) , unit (ring theory) , gerontology , psychology , sociology , gender studies , epistemology , philosophy , mathematics education

Low participation of Black Americans in cancer clinical trials is a well-established predicament. Many factors resulted in this current dilemma with racism being the fundamental unit. Here, we discuss some current challenges and proposed solutions to help in increasing the enrollment of Black Americans in cancer clinical trials. We suggest implementing the least acceptable race-specific percentage as a new bar that registrational clinical trials need to pass before cancer drugs approval. Clinical trials will continue to draw the future of cancer therapeutics in which we believe that a prompt improvement of Black Americans participation is warranted.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research